pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Coadministration of CYP3A4 inducers may lessen sufentanil degrees and efficacy, potentially precipitating withdrawal syndrome in sufferers that have made Bodily